Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
9.18M
-
Shares change
-
-135K
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
-$14.4M
-
Put/Call ratio
-
1.06
-
Number of buys
-
137
-
Number of sells
-
-110
-
Price
-
$115.35
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2022
314 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2022.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.18M shares
of 10.9M outstanding shares and own 84.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.85M shares), VANGUARD GROUP INC (1.68M shares), RENAISSANCE TECHNOLOGIES LLC (632K shares), STATE STREET CORP (370K shares), DIMENSIONAL FUND ADVISORS LP (335K shares), MORGAN STANLEY (291K shares), RICE HALL JAMES & ASSOCIATES, LLC (269K shares), PRINCIPAL FINANCIAL GROUP INC (231K shares), GEODE CAPITAL MANAGEMENT, LLC (218K shares), and PICTET ASSET MANAGEMENT SA (161K shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.